Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:1711082rdf:typepubmed:Citationlld:pubmed
pubmed-article:1711082lifeskim:mentionsumls-concept:C0020971lld:lifeskim
pubmed-article:1711082lifeskim:mentionsumls-concept:C0086427lld:lifeskim
pubmed-article:1711082lifeskim:mentionsumls-concept:C0020792lld:lifeskim
pubmed-article:1711082lifeskim:mentionsumls-concept:C0332307lld:lifeskim
pubmed-article:1711082lifeskim:mentionsumls-concept:C1622204lld:lifeskim
pubmed-article:1711082lifeskim:mentionsumls-concept:C0003320lld:lifeskim
pubmed-article:1711082lifeskim:mentionsumls-concept:C0003316lld:lifeskim
pubmed-article:1711082lifeskim:mentionsumls-concept:C0030956lld:lifeskim
pubmed-article:1711082lifeskim:mentionsumls-concept:C0475463lld:lifeskim
pubmed-article:1711082lifeskim:mentionsumls-concept:C1446680lld:lifeskim
pubmed-article:1711082lifeskim:mentionsumls-concept:C0205263lld:lifeskim
pubmed-article:1711082pubmed:issue1lld:pubmed
pubmed-article:1711082pubmed:dateCreated1991-7-23lld:pubmed
pubmed-article:1711082pubmed:abstractTextWe have generated a number of mAb against various epitopes on the external envelope glycoprotein, gp46, of human T cell leukemia virus type I (HTLV-I) from a WKA rat immunized with a recombinant vaccinia virus containing the HTLV-I env gene. Among these mAb, one group of mAb, represented by a mAb designated LAT-27, could neutralize the infectivity of HTLV-I, as determined by a HTLV-I-mediated cell fusion inhibition assay. LAT-27 also interfered with transformation of normal T lymphocytes by HTLV-I in vitro. An antibody-binding assay using overlapping synthetic oligopeptides showed that LAT-27 bound specifically to 10-mer peptides that contained the gp46 amino acid sequence 191-196 (Leu-Pro-His-Ser-Asn-Leu). Antibodies from HTLV-I+ humans interfered with the binding of LAT-27 to gp46 Ag. Sera from rabbits immunized with a LAT-27-reactive peptide, 190-199, conjugated with OVA, but not sera from OVA-immunized rabbits, reacted with gp46 Ag and neutralized infectivity of HTLV-I. These results show that the HTLV-I neutralization epitope recognized by LAT-27 locates to the gp46 amino acids 191-196, and that immunization with a peptide containing the LAT-27 epitope can elicit an HTLV-I neutralizing antibody response.lld:pubmed
pubmed-article:1711082pubmed:languageenglld:pubmed
pubmed-article:1711082pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1711082pubmed:citationSubsetAIMlld:pubmed
pubmed-article:1711082pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1711082pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1711082pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1711082pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1711082pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1711082pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1711082pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1711082pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1711082pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1711082pubmed:statusMEDLINElld:pubmed
pubmed-article:1711082pubmed:monthJullld:pubmed
pubmed-article:1711082pubmed:issn0022-1767lld:pubmed
pubmed-article:1711082pubmed:authorpubmed-author:TanakaYYlld:pubmed
pubmed-article:1711082pubmed:authorpubmed-author:ShirakiHHlld:pubmed
pubmed-article:1711082pubmed:authorpubmed-author:ShidaHHlld:pubmed
pubmed-article:1711082pubmed:authorpubmed-author:TozawaHHlld:pubmed
pubmed-article:1711082pubmed:authorpubmed-author:ZengLLlld:pubmed
pubmed-article:1711082pubmed:issnTypePrintlld:pubmed
pubmed-article:1711082pubmed:day1lld:pubmed
pubmed-article:1711082pubmed:volume147lld:pubmed
pubmed-article:1711082pubmed:ownerNLMlld:pubmed
pubmed-article:1711082pubmed:authorsCompleteYlld:pubmed
pubmed-article:1711082pubmed:pagination354-60lld:pubmed
pubmed-article:1711082pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:1711082pubmed:meshHeadingpubmed-meshheading:1711082-...lld:pubmed
pubmed-article:1711082pubmed:meshHeadingpubmed-meshheading:1711082-...lld:pubmed
pubmed-article:1711082pubmed:meshHeadingpubmed-meshheading:1711082-...lld:pubmed
pubmed-article:1711082pubmed:meshHeadingpubmed-meshheading:1711082-...lld:pubmed
pubmed-article:1711082pubmed:meshHeadingpubmed-meshheading:1711082-...lld:pubmed
pubmed-article:1711082pubmed:meshHeadingpubmed-meshheading:1711082-...lld:pubmed
pubmed-article:1711082pubmed:meshHeadingpubmed-meshheading:1711082-...lld:pubmed
pubmed-article:1711082pubmed:meshHeadingpubmed-meshheading:1711082-...lld:pubmed
pubmed-article:1711082pubmed:meshHeadingpubmed-meshheading:1711082-...lld:pubmed
pubmed-article:1711082pubmed:meshHeadingpubmed-meshheading:1711082-...lld:pubmed
pubmed-article:1711082pubmed:meshHeadingpubmed-meshheading:1711082-...lld:pubmed
pubmed-article:1711082pubmed:meshHeadingpubmed-meshheading:1711082-...lld:pubmed
pubmed-article:1711082pubmed:meshHeadingpubmed-meshheading:1711082-...lld:pubmed
pubmed-article:1711082pubmed:meshHeadingpubmed-meshheading:1711082-...lld:pubmed
pubmed-article:1711082pubmed:meshHeadingpubmed-meshheading:1711082-...lld:pubmed
pubmed-article:1711082pubmed:meshHeadingpubmed-meshheading:1711082-...lld:pubmed
pubmed-article:1711082pubmed:year1991lld:pubmed
pubmed-article:1711082pubmed:articleTitleIdentification of a neutralization epitope on the envelope gp46 antigen of human T cell leukemia virus type I and induction of neutralizing antibody by peptide immunization.lld:pubmed
pubmed-article:1711082pubmed:affiliationDepartment of Immunology, School of Hygienic Sciences, Kitasato University, Kanagawa, Japan.lld:pubmed
pubmed-article:1711082pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:1711082pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1711082lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1711082lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1711082lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1711082lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1711082lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1711082lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1711082lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1711082lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1711082lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1711082lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1711082lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1711082lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1711082lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1711082lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1711082lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1711082lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1711082lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1711082lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1711082lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1711082lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1711082lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1711082lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1711082lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1711082lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1711082lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1711082lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1711082lld:pubmed